Caroline Berube
Academic Appointments
- Clinical Associate Professor, Medicine - Hematology
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Hematology Clinic 875 Blake Wilbur Dr Clinic C MC 5820 Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 724-5203
- Academic Offices
Personal Information Email Tel (650) 498-6000Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Hematology
- Hemostasis Thrombosis
- Anticoagulation
- Hematology
- Anemia
- Idiopathic thrombocytopenic purpura
Administrative Appointments
- Medical Director, Oral Anticoagulation Clinic, Stanford Hospital and Clinics (2004 - present)
Professional Education
| Board Certification: | Medical Oncology, Royal College of Physicians and Surgeons of Canada (1990) |
| Board Certification: | Hematology, Royal College of Physicians and Surgeons (1989) |
| Board Certification: | Internal Medicine, Royal College of Physicians and Surgeons of Canada (1988) |
| Residency: | Laval University, Canada (1987) |
| Internship: | Laval University, Canada (1984) |
| Fellowship: | McMaster University, Canada (1991) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Clinical Trials
- Recruiting S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- Not Recruiting Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
- Not Recruiting Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Not Recruiting Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
- Not Recruiting A Study of CAL-101 and Rituximab in Elderly Patients With Untreated CLL or SLL
Publications
- Accessory splenules in autoimmune hemolytic anemia. Am J Hematol. 2013; (2): 156
- Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer. Am J Health Syst Pharm. 2011; (9): 814-7
- Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9. Pharmacogenet Genomics. 2010; (7): 407-13
- Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experience. Am J Hematol. 2010; (11): 877-81
- Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood. 2005; (8): 2865-70
Help
Trial Administration